# Philip Morris International Inc.: overview

PM · NYSE · CIK 1413329 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pm.md) · [Financials](/companies/pm/financials.md) · [Filings](/companies/pm/filings.md) · [Insiders](/companies/pm/insiders.md)

Latest reported revenue: [$11.44bn](/filings/0001628280-26-066976.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 23, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-066976).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [9.7 d](/filings/0001628280-26-005939.md) | [9.3](/filings/0001628280-26-027019.md) | [10.1](/filings/0001628280-26-049493.md) | [10.8](/filings/0001628280-26-066976.md) | [10.4 d](/filings/0001628280-26-005939.md) | [10.1](/filings/0001628280-26-027019.md) | [11.2](/filings/0001628280-26-049493.md) | [11.4](/filings/0001628280-26-066976.md) |
| Gross margin | % | [64.7% d](/filings/0001628280-26-005939.md) | [67.4%](/filings/0001628280-26-027019.md) | [67.7%](/filings/0001628280-26-049493.md) | [67.9%](/filings/0001628280-26-066976.md) | [65.5% d](/filings/0001628280-26-005939.md) | [68.1%](/filings/0001628280-26-027019.md) | [68.4%](/filings/0001628280-26-049493.md) | [68.7%](/filings/0001628280-26-066976.md) |
| Operating margin | % | [33.6% d](/filings/0001628280-26-005939.md) | [38.1%](/filings/0001628280-26-027019.md) | [36.6%](/filings/0001628280-26-049493.md) | [39.3%](/filings/0001628280-26-066976.md) | [32.6% d](/filings/0001628280-26-005939.md) | [38.4%](/filings/0001628280-26-027019.md) | [40.5%](/filings/0001628280-26-049493.md) | [42.5%](/filings/0001628280-26-066976.md) |
| Net margin | % | [(6.0%) d](/filings/0001628280-26-005939.md) | [28.9%](/filings/0001628280-26-027019.md) | [30.0%](/filings/0001628280-26-049493.md) | [32.1%](/filings/0001628280-26-066976.md) | [20.7% d](/filings/0001628280-26-005939.md) | [24.0%](/filings/0001628280-26-027019.md) | [25.2%](/filings/0001628280-26-049493.md) | [29.0%](/filings/0001628280-26-066976.md) |
| Diluted EPS | $ per share | not reported | [1.72](/filings/0001628280-26-027019.md) | [1.95](/filings/0001628280-26-049493.md) | [2.23](/filings/0001628280-26-066976.md) | not reported | [1.56](/filings/0001628280-26-027019.md) | [1.80](/filings/0001628280-26-049493.md) | [2.12](/filings/0001628280-26-066976.md) |
| Free cash flow | $bn | [3.7 d](/filings/0001628280-26-005939.md) | [(0.8)](/filings/0001628280-26-027019.md) | [3.1 d](/filings/0001628280-26-049493.md) | [4.1 d](/filings/0001628280-26-066976.md) | [4.3 d](/filings/0001628280-26-005939.md) | [(0.8)](/filings/0001628280-26-027019.md) | [5.1 d](/filings/0001628280-26-049493.md) | [5.0 d](/filings/0001628280-26-066976.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [31.4](/filings/0001413329-24-000013.md) | [31.8](/filings/0001413329-25-000013.md) | [35.2](/filings/0001628280-26-005939.md) | [37.9](/filings/0001628280-26-005939.md) | [40.6](/filings/0001628280-26-005939.md) |
| Gross margin | % | [68.1%](/filings/0001413329-24-000013.md) | [64.1%](/filings/0001413329-25-000013.md) | [63.3%](/filings/0001628280-26-005939.md) | [64.8%](/filings/0001628280-26-005939.md) | [67.1%](/filings/0001628280-26-005939.md) |
| Operating margin | % | [41.3%](/filings/0001413329-24-000013.md) | [38.6%](/filings/0001413329-25-000013.md) | [32.9%](/filings/0001628280-26-005939.md) | [35.4%](/filings/0001628280-26-005939.md) | [36.6%](/filings/0001628280-26-005939.md) |
| Net margin | % | [29.0%](/filings/0001413329-24-000013.md) | [28.5%](/filings/0001413329-25-000013.md) | [22.2%](/filings/0001628280-26-005939.md) | [18.6%](/filings/0001628280-26-005939.md) | [27.9%](/filings/0001628280-26-005939.md) |
| Diluted EPS | $ per share | [5.83](/filings/0001413329-24-000013.md) | [5.81](/filings/0001413329-25-000013.md) | [5.02](/filings/0001628280-26-005939.md) | [4.52](/filings/0001628280-26-005939.md) | [7.26](/filings/0001628280-26-005939.md) |
| Free cash flow | $bn | [11.2](/filings/0001413329-24-000013.md) | [9.7](/filings/0001413329-25-000013.md) | [7.9](/filings/0001628280-26-005939.md) | [10.8](/filings/0001628280-26-005939.md) | [10.7](/filings/0001628280-26-005939.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pm/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $24.09bn | 133,152,391 |  | Reduced −298,113 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $19.55bn | 108,039,522 |  | Added +507,449 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $18.41bn | 101,785,557 |  | Added +629,283 |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $15.24bn | 84,253,663 |  | Added +4,430,638 |
| [Capital International Investors](/funds/1562230.md) | 2026-06-30 | $13.07bn | 72,252,261 |  | Reduced −509,051 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $10.13bn | 55,569,994 |  | Added +536,968 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $8.81bn | 48,189,101 |  | Reduced −3,402,096 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $8.42bn | 46,521,326 |  | Added +1,750,723 |
| [GQG Partners LLC](/funds/1697233.md) | 2026-06-30 | $8.22bn | 45,436,985 |  | Reduced −4,668,915 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $7.06bn | 39,038,598 |  | Added +577,415 |

## Recent filings

[All 1,973 filings](/companies/pm/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 07:07 ET | [10-Q](/filings/0001628280-26-066976.md) | Quarterly report, period 2026-09-30 | 0001628280-26-066976 |
| 2026-10-21 | 11:04 ET | [8-K](/filings/0001628280-26-066596.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-066596 |
| 2026-09-18 | 12:04 ET | [8-K](/filings/0001628280-26-062621.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-062621 |
| 2026-09-08 | 13:46 ET | [8-K](/filings/0001628280-26-060822.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-060822 |
| 2026-09-08 | 11:37 ET | [8-K](/filings/0001628280-26-060806.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-060806 |
| 2026-08-24 | 11:02 ET | [8-K](/filings/0001628280-26-058513.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-058513 |
| 2026-07-24 | 10:44 ET | [10-Q](/filings/0001628280-26-049493.md) | Quarterly report, period 2026-06-30 | 0001628280-26-049493 |
| 2026-07-22 | 11:02 ET | [8-K](/filings/0001628280-26-049107.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-049107 |
| 2026-07-09 | 20:05 ET | [8-K](/filings/0001628280-26-047782.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-047782 |
| 2026-06-29 | 20:05 ET | [8-K](/filings/0001104659-26-078814.md) | 8.01 Other events | 0001104659-26-078814 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-005939.md), filed Feb 6, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1413329
- Tickers: PM
- Exchange: NYSE
- SIC code: 2111 Cigarettes
- State of incorporation: VA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.
